DanCann Pharma Feed

Land	Danmark
Lista	Spotlight DK
Sektor	Hälsovård
Industri	Läkemedel & Handel

2022-09-22 13:00:00 DanCann Pharma A/S has appointed Alexander Schoeneck and Jeppe Krog Rasmussen to the Board of Directors +6,12% | 0,05 MDKK

2022-09-20 15:10:51 DanCann Pharma A/S: Minutes of annual general meeting +2,44% | 0,07 MDKK

2022-09-12 10:00:00 DanCann Pharma A/S: Pain specialist Tina Horsted and DanCann Pharma A/S in collaboration on ambitious patient project -13,39% | 0,32 MDKK

2022-09-05 13:55:00 DanCann Pharma A/S: Carsten Trads, Chairman, comments on the Rights Issue +0,62% | 0,36 MDKK

2022-09-05 08:00:00 DanCann Pharma A/S: Notice of extraordinary general meeting +0,62% | 0,36 MDKK

2022-08-31 08:30:00 DanCann Pharma A/S intends to resolve on a partially (77 percent) guaranteed rights issue of approximately DKK 28.5 million -58,33% | 3,59 MDKK

2022-08-31 08:00:00 DanCann Pharma A/S publishes Q2-2022 report -58,33% | 3,59 MDKK

2022-08-29 15:50:00 DanCann Pharma A/S signs supply agreement with WEECO Pharma GmbH worth DKK 40 million +16,28% | 0,82 MDKK

2022-08-24 09:00:00 DanCann Pharma A/S: According to a recent opinion poll a majority of Danes are positive towards legalization of cannabis 0,00% | 0,07 MDKK

2022-08-19 19:00:00 DanCann Pharma A/S postpones quarterly report for Q2 2022 0,00% | 0,06 MDKK

2022-08-19 09:00:00 DanCann Pharma A/S: Standardized medicinal cannabis products are essential for the medical profession - and ultimately for the patients 0,00% | 0,10 MDKK

2022-08-16 09:00:00 DanCann Pharma A/S appoints Charlotte Hagedorn Jørgensen as new Head of Quality Assurance -0,89% | 0,15 MDKK

2022-08-11 09:00:00 DanCann Pharma A/S: CEO Jeppe Krog Rasmussen appointed to the board of The Danish Association of Listed Growth Companies -3,80% | 0,12 MDKK

2022-08-05 10:00:00 DanCann Pharma A/S: The acquisition of CannGros ApS shows a prominent EBITDA of DKK 1.6 million for the annual 2021-report +0,39% | 0,18 MDKK

2022-07-15 18:20:00 DanCann Pharma A/S has prolonged its loan facility of SEK 13.7 million +0,40% | 0,05 MDKK

2022-05-18 17:00:00 DanCann Pharma A/S publishes Q1-2022 report: Facing commercialization stage +14,15% | 0,35 MDKK

2022-05-16 11:00:00 DanCann Pharma A/S: Establishing a new benchmark in the industry as impressive test results show extreme product purity without the use of radiation +8,00% | 0,12 MDKK

2022-05-12 09:00:00 DanCann Pharma A/S signs Letter of Intent with Aureum Pharma AB for exclusive rights with a minimum commitment of SEK 37 million -4,61% | 0,57 MDKK

2022-05-10 10:00:00 DanCann Pharma A/S appoints Martin Vedel Ernst as new Chief Financial Officer -1,27% | 0,11 MDKK

2022-05-06 10:00:00 DanCann Pharma's CEO: Building organization and strong results from the acquisition of CannGros ApS +3,21% | 0,07 MDKK

2022-05-02 10:30:00 DanCann Pharma A/S strengthens the Board of Directors with experienced investment profile Tue Østergaard -7,17% | 0,17 MDKK

2022-04-27 15:00:00 DanCann Pharma A/S: Minutes of annual general meeting -4,62% | 0,15 MDKK

2022-04-13 14:00:00 Correction: DanCann Pharma A/S publishes Annual Report 2021 -1,45% | 0,54 MDKK

2022-04-13 08:00:00 DanCann Pharma A/S nominates Tue Østergaard to the Board of Directors at the Company's Annual General Meeting -1,45% | 0,54 MDKK

2022-04-12 22:30:00 Correction: DanCann Pharma A/S Announces the appointment of Louise Conradsen to accelerate growth as new subsidiary CEO of CannGros ApS -1,45% | 0,54 MDKK

2022-04-12 17:40:00 DanCann Pharma A/S Announces the appointment of Louise Conradsen as new Chief Executive Officer to accelerate growth of CannGros ApS -1,45% | 0,54 MDKK

2022-04-12 17:35:00 DanCann Pharma A/S: NOTICE OF ANNUAL GENERAL MEETING -1,45% | 0,54 MDKK

2022-04-12 17:32:00 DanCann Pharma A/S: Independent auditor's report -1,45% | 0,54 MDKK

2022-04-12 17:30:00 DanCann Pharma A/S publishes Annual Report 2021 -1,45% | 0,54 MDKK

2022-04-01 13:00:00 DanCann Pharma A/S: Correction of press release on notice of the Annual General Meeting of shareholders -3,71% | 0,35 MDKK

2022-03-28 14:40:00 DanCann Pharma A/S appoints Sarah Mai Lykke-Kjeldsen as new COO -4,39% | 0,39 MDKK

2022-03-28 14:30:00 DanCann Pharma A/S: CFO Mads Møller Kristensen and DanCann Pharma will be parting ways as of 31 May 2022 -4,39% | 0,39 MDKK

2022-03-21 12:30:00 DanCann Pharma A/S: Postponement of the Annual General Meeting of shareholders +4,74% | 0,06 MDKK

2022-03-17 14:00:00 DanCann Pharma A/S named "Entrepreneur of the Year 2021" in Varde Municipality -1,56% | 0,34 MDKK

2022-02-25 09:00:00 DanCann Pharma A/S publishes Q4-2021 report +2,63% | 0,39 MDKK

2022-02-21 09:00:00 26-year-old Jeppe Krog Rasmussen, CEO of DanCann Pharma A/S, listed as one of the greatest business management talents in Denmark by leading Danish newspaper Berlingske -6,75% | 0,24 MDKK

2022-02-09 09:00:00 DanCann Pharma A/S has submitted application to the Danish Medicines Agency for EU-GMP-approval for Biotech Pharm1 -1,83% | 0,50 MDKK

2022-01-19 09:00:00 DanCann Pharma A/S: Highly promising analysis results +3,73% | 1,51 MDKK

2022-01-17 08:50:00 DanCann Pharma A/S: Strong Support from the DanCann Pharma Board of Directors, who convert their warrants into shares and buy more than 80,000 shares equaling DKK +400,000 -11,91% | 1,39 MDKK

2022-01-17 08:45:00 DanCann Pharma A/S Announces Exercise of Warrants for Proceeds of DKK approx. DKK 9.3 million to Strengthen the Financial Position -11,91% | 1,39 MDKK

2022-01-07 13:15:00 DanCann Pharma A/S: EUROPEAN UNION INTELLECTUAL PROPERTY OFFICE CERTIFICATE OF REGISTRATION for product portfolio trademarks -0,94% | 1,24 MDKK

2022-01-04 15:30:00 DanCann Pharma A/S: Morten Martinsen, COO, sells minor position of shares in DanCann Pharma +2,88% | 2,40 MDKK

2021-12-30 08:30:00 DanCann Pharma A/S: Germanys intention to legalize cannabis is a gamechanger for Europe +14,38% | 3,93 MDKK

2021-12-17 08:00:00 DanCann Pharma A/S: CEO, Jeppe Krog Rasmussen (Xignotus Capital ApS), locks his position in DanCann Pharma for 3 years - and thereby more than 21% of the total share capital +10,20% | 1,29 MDKK

2021-12-02 15:45:00 DanCann Pharma A/S: It's official: A permanent scheme for medical cannabis in Denmark +7,22% | 1,53 MDKK

2021-11-30 08:30:00 DanCann Pharma A/S: Tetra Bio-Pharma Announces Positive Initial Clinical Data from Both of its Ongoing Phase 2 Clinical Trials of QIXLEEF™ +8,70% | 2,37 MDKK

2021-11-26 09:00:00 DanCann Pharma A/S publishes Q3-2021 report 0,00% | 0,56 MDKK

2021-10-22 08:45:00 DanCann Pharma A/S: Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug Designation for QIXLEEF™ from the European Medicines Agency +0,67% | 0,74 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2022-11-23	Kvartalsrapport 2022-Q3
2022-09-20	Extra Bolagsstämma 2022
2022-08-31	Kvartalsrapport 2022-Q2
2022-05-18	Kvartalsrapport 2022-Q1
2022-04-27	Årsstämma 2022
2022-04-08	Ordinarie utdelning DANCAN 0.00 DKK
2022-02-25	Bokslutskommuniké 2021
2021-11-26	Kvartalsrapport 2021-Q3
2021-08-27	Kvartalsrapport 2021-Q2
2021-07-23	Extra Bolagsstämma 2021
2021-05-28	Kvartalsrapport 2021-Q1
2021-04-29	Ordinarie utdelning DANCAN 0.00 DKK
2021-04-28	Årsstämma 2021
2021-02-26	Bokslutskommuniké 2020

DanCann Pharma

Beskrivning

Kalender

DanCann Pharma

Beskrivning

Kalender

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden